Australia's most trusted
source of pharma news
Tuesday, 24 February 2026
Tuesday, 24 February 2026
Subscribe
Login
2026 burnout takes hold... already
Just seven weeks into 2026, industry has already hit burnout with pharma employees buckling under the strain of working in multiple roles and across gruelling hours, according to an industry coaching expert.
Arrotex inks fresh licensing deal
Company forges path into the innovative medicines space announcing an exclusive licensing deal with a Taiwan-based pharma
TODAY
Global pharma eyes Aussie drug
Clinical collaboration to trial a combination treatment in Australia for late-stage cancers set to commence later this year
TODAY
Fallen blockbusters shake up PBS
Loss of exclusivity saw a shake-up in the highest PBS earners list in 2025, although one giant drug has beaten off generic competition
23 February
Aussie company sells for $1.6B
After making its mark selling compounded semaglutide via telehealth, this company has been snapped up by a US giant
23 February
Staff exit over work policy gap
Pharma funded survey finds 39 per cent of employees undergoing fertility treatment are leaving or considering leaving their jobs
20 February
20+ companies hit PBS bottleneck
Find out who is in the running to secure a PBS listing in March, with seven brand-new drugs on the cards
19 February
Latest Jobs
Materials PlannerCustomer Service RepresentativeSenior Manager, Clinical Operations (Japan)Senior Manager, Regulatory Affairs OperationsSenior Clinical Project ManagerAssociate Director Regulatory Operations (Japan)Regulatory & Quality ManagerProcurement Specialist30 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (11)
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - St Leonards
- Territory Manager - Capital Equipment - Melbourne
- Junior Accountant - Sydney
- Territory Manager - Melbourne
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
Clinical & Medical, R&D (6)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Clinical Project Manager - Tokyo, Japan
- Quality & Medical Operations Specialist - Sydney
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
Regulatory, Pharmacovigilance & QA (5)
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
- Senior Quality Associate - New South Wales
- Quality & Medical Operations Specialist - Sydney
Executive Roles (4)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Associate Business Development Director - Clinical Research, China - Shanghai, China
Other (17)
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
- Re-manufacturing Operator - New South Wales
- Warehouse Assistant - Blacktown
- Pharmacy Assistant - Toongabbie
- QC Analyst -Biochemistry - Melbourne
- SAP Project Lead - Brisbane
- Logistics Manager - Sydney
- Finance Manager - Melbourne
- Senior Recruitment Consultant - Victoria
- Distribution and Warehouse Technician - Broadmeadows
- Recruitment Consultant - Sydney
- Warehouse Associate - Chatswood
- Logistics Specialist - Macquarie Park
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
Pharma future looking up? Maybe
While there's been an upturn in sentiment it's nowhere near enough to quash overwhelming concern about the current state of industry
23 February
GSK rebrands shingles campaign
Long-running campaign rebranded after finding awareness alone just isn't cutting it, with an AFL legend and his father joining the cause
23 February
TGA approves new ADC
This pharma has finally registered its first-in-class drug, months after securing the PBAC's recommendation
23 February Approvals Action
Obesity battle, now a war of words?
When it comes to controlling the narrative around obesity drugs, one company is blitzing it by winning hearts and minds
20 February
Pharma execs swamp job webinar
Registrations go viral so could this be pharma's hottest role? Plus the other most popular stories this week
20 February Your Week in 5 Minutes
Big year for novel drug approvals
More than 40 novel drugs secured their first approval last year but only a tiny fraction reached Australia. See the list
20 February
Seqirus wipes out rival's patents
A couple of patents covering mRNA vaccines are no longer valid, as two vaccine giants jostle over access to the market
20 February
Meet Pharma's Most Influential
TIME has released its list of the 100 people most influential in health, find out which pharma leaders made the cut
19 February
Novo backs Aussie town with $3M
The obesity giant is funding a program to improve children's health through nourishing food and exercise, in this fast-growing area
19 February
CSL strikes $100M deal with Lilly
Licensing agreement for a promising therapeutic candidate gives Lilly rights in all potential indications... except one
19 February
Deal failure sparks damages fight
ASX listed Mayne Pharma has taken US-based Cosette to court seeking "substantial damages" after a sale agreement fell over
19 February
Is this pharma's hottest career?
Aussie webinar swamped, underlining the popularity of this function and raising questions about career paths
18 February
Roche taps Aussie for big HQ job
After 12 years in his current Melbourne-based role, this high-flyer is packing his bags for Basel and an impressive global position
18 February
China charges AZ with illegal trade
Two former senior executives also facing charges with a $25 million fine looming for the company if it is found liable
18 February